Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis
- PMID: 11885838
Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis
Similar articles
-
Bladder cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide.Acta Urol Belg. 1991;59(1):133-7. Acta Urol Belg. 1991. PMID: 1927758 No abstract available.
-
Bladder cancer after cyclophosphamide therapy for lupus nephritis.Nephron. 1992;60(3):378-9. doi: 10.1159/000186790. Nephron. 1992. PMID: 1565199 No abstract available.
-
[Urothelial carcinoma of the bladder following cyclophosphamide therapy].Z Urol Nephrol. 1984 Jan;77(1):7-9. Z Urol Nephrol. 1984. PMID: 6702330 German.
-
[Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].Hinyokika Kiyo. 1991 Apr;37(4):393-6. Hinyokika Kiyo. 1991. PMID: 1891999 Review. Japanese.
-
[Urothelial carcinoma after treatment with cyclophosphamide. Review of the literature and presentation of our caseload].Actas Urol Esp. 1993 Feb;17(2):139-42. Actas Urol Esp. 1993. PMID: 8480522 Review. Spanish.
Cited by
-
Incidence of cancer among female patients with systemic lupus erythematosus in Korea.Clin Rheumatol. 2010 Apr;29(4):381-8. doi: 10.1007/s10067-009-1332-7. Epub 2009 Dec 30. Clin Rheumatol. 2010. PMID: 20041274
-
Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies.Front Oncol. 2022 May 4;12:860794. doi: 10.3389/fonc.2022.860794. eCollection 2022. Front Oncol. 2022. PMID: 35600353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical